| Net Cash Provided by (Used in) Operating Activities |
19.2M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-21.1M |
USD |
-334% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
621K |
shares |
+7.13% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.85M |
USD |
-310% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
5.32M |
USD |
+13.5% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.85M |
USD |
-10% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
606M |
USD |
+6.75% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
657M |
USD |
|
Q1 2025 |
Q1 2025 |
| Interest Expense |
7.14M |
USD |
+56.1% |
Q2 2024 |
Q2 2024 |